ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 263 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,382,471 | +1.3% | 44,164 | -32.5% | 0.01% | 0.0% |
| Q3 2023 | $1,364,061 | -10.7% | 65,454 | +2.6% | 0.01% | -16.7% |
| Q2 2023 | $1,527,268 | +10081.8% | 63,769 | +5967.5% | 0.01% | – |
| Q2 2022 | $15,000 | -71.7% | 1,051 | -51.9% | 0.00% | – |
| Q1 2022 | $53,000 | +8.2% | 2,184 | +4.9% | 0.00% | – |
| Q4 2021 | $49,000 | +250.0% | 2,081 | +156.0% | 0.00% | – |
| Q3 2021 | $14,000 | -74.1% | 813 | -62.9% | 0.00% | -100.0% |
| Q2 2021 | $54,000 | -18.2% | 2,194 | -13.7% | 0.00% | 0.0% |
| Q1 2021 | $66,000 | -30.5% | 2,543 | +42.5% | 0.00% | 0.0% |
| Q4 2020 | $95,000 | +1087.5% | 1,785 | +1090.0% | 0.00% | – |
| Q2 2020 | $8,000 | -11.1% | 150 | -57.1% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +50.0% | 350 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -60.0% | 350 | -51.2% | 0.00% | -100.0% |
| Q3 2018 | $15,000 | 0.0% | 717 | -29.4% | 0.00% | 0.0% |
| Q2 2018 | $15,000 | +66.7% | 1,015 | +125.6% | 0.00% | 0.0% |
| Q1 2018 | $9,000 | -47.1% | 450 | -18.2% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | +70.0% | 550 | +57.1% | 0.00% | – |
| Q3 2017 | $10,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |